Related references
Note: Only part of the references are listed.A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat
Richard E. Gilbert et al.
PLOS ONE (2012)
Fluorofenidone Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice
Ling Hao Wang et al.
PHARMACOLOGY (2011)
Fluorofenidone attenuates collagen I and transforming growth factor-β1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells
Zhang-Zhe Peng et al.
NEPHROLOGY (2009)
The Podocyte in Diabetic Kidney Disease
Erin Stitt-Cavanagh et al.
THESCIENTIFICWORLDJOURNAL (2009)
Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease
K Susztak et al.
DIABETES (2004)
Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice
MP Cohen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
